Mapping to Estimate Health-State Utility from Non-Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report.
暂无分享,去创建一个
Andrea Manca | Joshua Ray | Jan Busschbach | Bruce Crawford | A. Wailoo | A. Manca | M. Botteman | J. Ray | J. Busschbach | Marc Botteman | B. Crawford | Monica Hernandez-Alava | Allan J Wailoo | Aurelio Mejia | Mónica Hernández-Alava | A. Mejía
[1] J. S. Cramer,et al. Econometric Applications of Maximum Likelihood Methods , 1986 .
[2] S. Davis,et al. Mapping from the Health Assessment Questionnaire to the EQ-5D: the impact of different algorithms on cost-effectiveness results. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[3] Albert W Wu,et al. Addressing ceiling effects in health status measures: a comparison of techniques applied to measures for people with HIV disease. , 2007, Health services research.
[4] S. Brophy,et al. Modeling Health State Utility Values in Ankylosing Spondylitis: Comparisons of Direct and Indirect Methods. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[5] Allan Wailoo,et al. A Comparison of Direct and Indirect Methods for the Estimation of Health Utilities from Clinical Outcomes , 2014, Medical decision making : an international journal of the Society for Medical Decision Making.
[6] K. Abrams,et al. Good Practice Guidelines for the use of Statistical Regression Models in Economic Evaluations , 2013, PharmacoEconomics.
[7] Andrew Briggs,et al. Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report. , 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[8] Oliver Rivero-Arias,et al. Estimating the Association between SF-12 Responses and EQ-5D Utility Values by Response Mapping , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.
[9] Andrew Briggs,et al. Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences , 2010, The European Journal of Health Economics.
[10] Roberta Ara,et al. Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[11] A. Wailoo,et al. Modelling the relationship between the WOMAC osteoarthritis index and EQ-5D , 2013, Health and Quality of Life Outcomes.
[12] Julia Earnshaw,et al. NICE Guide to the Methods of Technology Appraisal , 2012, PharmacoEconomics.
[13] J. Brazier,et al. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. , 2014, Health technology assessment.
[14] Andrea Manca,et al. Prediction of patient‐reported outcome measures via multivariate ordered probit models , 2015 .
[15] Mark Oppe,et al. Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement. , 2015, Journal of medical economics.
[16] David Parkin,et al. Using the EQ-5D as a performance measurement tool in the NHS , 2009 .
[17] John Brazier,et al. The Use of Health State Utility Values in Decision Models , 2017, PharmacoEconomics.
[18] D. Feeny,et al. The Health Utilities Index (HUI®): concepts, measurement properties and applications , 2003, Health and quality of life outcomes.
[19] R. Goeree,et al. Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate? , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[20] Sarah E Lamb,et al. Mapping between the Roland Morris Questionnaire and generic preference-based measures. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[21] Aki Tsuchiya,et al. Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis. , 2007, Arthritis and rheumatism.
[22] Nicky J Welton,et al. NICE DSU Technical Support Document 18 , 2011 .
[23] M. Weinstein,et al. Foundations of cost-effectiveness analysis for health and medical practices. , 1977, The New England journal of medicine.
[24] Jerry G. Thursby,et al. Econometric Applications of Maximum Likelihood Methods. , 1988 .
[25] A. Brennan,et al. The Sheffield rheumatoid arthritis health economic model. , 2011, Rheumatology.
[26] A. Williams. EuroQol : a new facility for the measurement of health-related quality of life , 1990 .
[27] S. Acaster,et al. Mapping the EQ-5D index from the cystic fibrosis questionnaire-revised using multiple modelling approaches , 2015, Health and Quality of Life Outcomes.
[28] J. Brazier,et al. The Estimation of a Preference-Based Measure of Health From the SF-12 , 2004, Medical care.
[29] J. Brazier,et al. Deriving preference-based single indices from non-preference based condition-specific instruments: converting AQLQ into EQ5D indices , 2002 .
[30] Andrew Gelman,et al. Inference from Simulations and Monitoring Convergence , 2011 .
[31] Matthias Hunger,et al. Analysis of SF-6D index data: is beta regression appropriate? , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[32] Andrea Manca,et al. Regression Estimators for Generic Health-Related Quality of Life and Quality-Adjusted Life Years , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.
[33] Anna García-Altés,et al. Spanish recommendations on economic evaluation of health technologies , 2010, The European Journal of Health Economics.
[34] Aki Tsuchiya,et al. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures , 2010, The European Journal of Health Economics.